Showing 1631-1640 of 6983 results for "".
Microneedling v. Fractional Resurfacing: When and Why
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/microneedling-v-fractional-resurfacing-when-and-why/19688/Data suggest that microneedling can be as effective as nonablative fractional resurfacing for improvement of acne scars. So when is each indicated? Deirdre Hooper, MD discusses a role for combination approaches.Advances in Skin Cancer Detection
https://practicaldermatology.com/topics/skin-cancer-photoprotection/advances-in-skin-cancer-detection/19685/Early detection is the best defense against skin cancers, and new technologies are assisting in the fight, says Anthony Rossi, MD. He highlights new and emerging advancements.Why your dermatology practice isn’t ranking well on Google
https://practicaldermatology.com/topics/practice-management/why-your-dermatology-practice-isnt-ranking-well-on-google/19647/If your dermatology website isn’t ranking well on Google, there are hundreds of possible reasons why. However, in many cases the answer is quite simple. This Ekwa Marketing video explains some of the most common mistakes, and what to do about them.Put your dermatology practice on the map with Google my Business
https://practicaldermatology.com/topics/practice-management/put-your-dermatology-practice-on-the-map-with-google-my-business/19633/Have you ever wondered why Google maps shows so much information about some dermatology practices, and so little about others? The answer is “Google my Business.” This video from Ekwa Marketing explains what it is, and how to optimize your profile.DermWireTV: AbbVie to Acquire Allergan, Duobrii Launches, SDPA at 25
https://practicaldermatology.com/topics/psoriasis/dermwiretv-abbvie-to-acquire-allergan-duobrii-launches-sdpa-at-25/19629/In a deal with an equity value of approximately $63 billion, AbbVie has agreed to acquire Allergan. The new company is positioned for new growth platforms and a diversified revenue base; the deal will be immediately accretive to earnings per share, AbbVie says. The Society of Dermatology Physician AThe Skin Cancer Foundation at 40
https://practicaldermatology.com/topics/skin-cancer-photoprotection/the-skin-cancer-foundation-at-40/19614/Skin Cancer Foundation president Deborah Sarnoff, MD talks about the Foundation's accomplishments, its current focus, and future goals. Founded in 1979, the foundation has helped educate the public on skin cancer risk and supports dermatologists in practice.BTL, Sciton Updates; Sun Gets PsO Real
https://practicaldermatology.com/topics/psoriasis/dermwire-tv-btl-sciton-updates-sun-gets-pso-real/19601/BTL rolls out a small Emsculpt applicator to treat arms, thighs and calves at ASLMS. Sciton introduces JOULE X. In conjunction with Sun Pharma, the Association for Applied and Therapeutic Humor is offering strategies to help psoriasis patients navigate emotional challenges and uncomfortable psoriasiThe Viability of Phototherapy
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/the-viability-of-phototherapy/18373/The excellent safety profile of phototherapy makes it a viable treatment option for many patients with psoriasis, even in an age of biologics, says Elma Baron, MD. Efficacy of phototherapy is high, she says.Sunscreen Ratings, Long Live Skin Launches, SCALE Highlights
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-sunscreen-ratings-long-live-skin-launches-scale-highlights/18471/Consumer Reports says that one-third of sunscreens tested in its latest evaluation provided less than half of the SPF protection touted on the label. For its part, the American Academy of Dermatology is reminding patients that sunscreen ingredients are safe. The Environmental Working Group continuesFiller Considerations for Men
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/filler-considerations-for-men/18492/Understanding the underlying anatomy is essential to proper use of filler and neurotoxins in men—and women. Shannon Humphrey, MD explains.